If you have been diagnosed with colorectal cancer, you may receive a chemotherapy medication called Stivarga® (regorafenib). This prescription medicine is specifically approved for treating colorectal cancer (cancer of the colon and rectum) that has spread to other areas of the body (metastasized) in adults. Stivarga is used when other treatment has been tried, but the disease progresses.
Stivarga is manufactured by Bayer HealthCare Pharmaceuticals, Inc. It is not available as a generic at this time due to certain patents. However, once these patents expire, companies may be allowed to make a generic version of Stivarga.
(Click Stivarga for a closer look at what this chemotherapy drug is used for, how it works, and dosing instructions. It also describes possible side effects and explains why this drug is not appropriate for some people.)
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Food and Drug Administration (FDA) news release. FDA approves new treatment for advanced colorectal cancer. September 27, 2012. Available at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm321271.htm. Accessed October 9, 2012.
Micromedex 2.0 Healthcare Series [Internet database]. Greenwood Village, Colo: Thomson Reuters (Healthcare), Inc. Updated periodically. Accessed October 9, 2012.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click